Ottobock SE & Co. KGaA (Ticker: OBCK GR) is a Germany-based MedTech company focused on custom orthotics and prosthetics, neuro-orthotics and exoskeletons. The company plans to list on the Frankfurt Stock Exchange on 9 October 2025 at EUR 62.00–66.00 per share. The IPO includes 1.6m new shares, 9.1m existing shares and a 1.6m-share greenshoe. At the midpoint, the offer volume is EUR 787 million (USD 921 million), implying a market capitalization of EUR 4.1 billion (USD 4.8 billion). Expected free float is about 19%. Cornerstone investors include Kühne Holding (up to EUR 125m, capped at 2.99%) and SMALLCAP World Fund Inc. (up to EUR 115m). Gross proceeds of ~EUR 100m from new shares target financial flexibility, technology investments, and opportunities in Products & Components and Patient Care M&A.